Pacific Capital Partners LTD Exact Sciences Corp Transaction History

Pacific Capital Partners LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 May 08, 2025	BUY	$49.33 - $71.97 $1.41 Million - $2.05 Million	28,500 New	28,500 $1.6 Billion
Q3 2024 May 08, 2025	BUY	$42.43 - $70.83 $1.21 Million - $2.02 Million	28,500 New	28,500 $1.94 Billion
Q2 2024 May 08, 2025	BUY	$41.33 - $74.26 $490,256 - $880,872	11,862 Added 71.29%	28,500 $1.2 Million
Q1 2024 May 08, 2025	BUY	$56.27 - $73.77 $205,779 - $269,776	3,657 Added 28.17%	16,638 $1.15 Billion
Q4 2023 May 08, 2025	BUY	$59.06 - $75.72 $221,120 - $283,495	3,744 Added 40.53%	12,981 $960 Million

Q3 2023 May 08, 2025	BUY	$65.94 - $99.04 $609,087 - $914,832	9,237 New	9,237 $630 Million

670

164M

2.2M

1.69M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.9B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Pacific Capital Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Pacific Capital Partners LTD with notifications on news.